223 related articles for article (PubMed ID: 18838476)
1. Chromosomal instability syndromes are sensitive to poly ADP-ribose polymerase inhibitors.
Gaymes TJ; Shall S; Farzaneh F; Mufti GJ
Haematologica; 2008 Dec; 93(12):1886-9. PubMed ID: 18838476
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribose) polymerase mediates the suicide response to massive DNA damage: studies in normal and DNA-repair defective cells.
Berger NA; Sims JL; Catino DM; Berger SJ
Princess Takamatsu Symp; 1983; 13():219-26. PubMed ID: 6317637
[TBL] [Abstract][Full Text] [Related]
3. [Poly-(ADP ribose) synthesis and regulation disorders in disease].
Altmann H
Wien Klin Wochenschr; 1983 Dec; 95(24):861-4. PubMed ID: 6422646
[TBL] [Abstract][Full Text] [Related]
4. Poly(ADP-ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic.
Yap TA; Sandhu SK; Carden CP; de Bono JS
CA Cancer J Clin; 2011; 61(1):31-49. PubMed ID: 21205831
[TBL] [Abstract][Full Text] [Related]
5. Efficient deletion of normal Brca2-deficient intestinal epithelium by poly(ADP-ribose) polymerase inhibition models potential prophylactic therapy.
Hay T; Jenkins H; Sansom OJ; Martin NM; Smith GC; Clarke AR
Cancer Res; 2005 Nov; 65(22):10145-8. PubMed ID: 16287996
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of homologous recombination by treatment with BVDU (brivudin) or by RAD51 silencing increases chromosomal damage induced by bleomycin in mismatch repair-deficient tumour cells.
Vernole P; Muzi A; Volpi A; Dorio AS; Terrinoni A; Shah GM; Graziani G
Mutat Res; 2009 May; 664(1-2):39-47. PubMed ID: 19428379
[TBL] [Abstract][Full Text] [Related]
7. Baseline sister chromatid exchange in human cell lines with different levels of poly(ADP-ribose) polymerase.
Jorgensen TJ; Leonard JC; Thraves PJ; Dritschilo A
Radiat Res; 1991 Jul; 127(1):107-10. PubMed ID: 1906188
[TBL] [Abstract][Full Text] [Related]
8. Effect of poly(adenosine diphosphate-ribose) polymerase inhibitors on neocarzinostatin-induced G2 delay in HeLa-S3 cells.
Iseki S; Mori T
Cancer Res; 1985 Sep; 45(9):4224-8. PubMed ID: 2992774
[TBL] [Abstract][Full Text] [Related]
9. Targeting DNA repair pathways in AML.
D'Andrea AD
Best Pract Res Clin Haematol; 2010 Dec; 23(4):469-73. PubMed ID: 21130409
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribose) polymerase inhibitors as potential chemotherapeutic agents.
Bryant HE; Helleday T
Biochem Soc Trans; 2004 Dec; 32(Pt 6):959-61. PubMed ID: 15506935
[TBL] [Abstract][Full Text] [Related]
11. Radiosensitization of human and rodent cell lines by INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase.
Brock WA; Milas L; Bergh S; Lo R; Szabó C; Mason KA
Cancer Lett; 2004 Mar; 205(2):155-60. PubMed ID: 15036647
[TBL] [Abstract][Full Text] [Related]
12. Current development of clinical inhibitors of poly(ADP-ribose) polymerase in oncology.
Ratnam K; Low JA
Clin Cancer Res; 2007 Mar; 13(5):1383-8. PubMed ID: 17332279
[TBL] [Abstract][Full Text] [Related]
13. An improved nonisotopic test to screen a large series of new inhibitor molecules of poly(ADP-ribose) polymerase activity for therapeutic applications.
Decker P; Miranda EA; de Murcia G; Muller S
Clin Cancer Res; 1999 May; 5(5):1169-72. PubMed ID: 10353753
[TBL] [Abstract][Full Text] [Related]
14. [Effect of inhibitors of topoisomerases and poly(ADP-ribosylation) on homologous and non-homologous integration of exogenous DNA in genes of mammalian somatic cells].
Shcherbakova OG; Smirnova TV; Filatov MV
Tsitologiia; 1999; 41(11):946-51. PubMed ID: 10643051
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of poly(ADP-ribose) polymerase in cancer.
Plummer ER
Curr Opin Pharmacol; 2006 Aug; 6(4):364-8. PubMed ID: 16753340
[TBL] [Abstract][Full Text] [Related]
16. Participation of Poly(ADP-ribose)-polymerase of nuclear matrix in DNA repair.
Zaalishvili TM; Gabriadze IY; Margiani DO; Philauri VR; Surguladze NM
Biochemistry (Mosc); 2000 Jun; 65(6):659-61. PubMed ID: 10887283
[TBL] [Abstract][Full Text] [Related]
17. Clinical poly(ADP-ribose) polymerase inhibitors for the treatment of cancer.
Lewis C; Low JA
Curr Opin Investig Drugs; 2007 Dec; 8(12):1051-6. PubMed ID: 18058575
[TBL] [Abstract][Full Text] [Related]
18. [Chromosome instability syndromes].
Germain D; Bernheim A
Sem Hop; 1983 Dec; 59(44):3065-79. PubMed ID: 6320395
[TBL] [Abstract][Full Text] [Related]
19. Enhanced non-homologous end joining contributes toward synthetic lethality of pathological RAD51C mutants with poly (ADP-ribose) polymerase.
Somyajit K; Mishra A; Jameei A; Nagaraju G
Carcinogenesis; 2015 Jan; 36(1):13-24. PubMed ID: 25292178
[TBL] [Abstract][Full Text] [Related]
20. The potential of PARP inhibitors in genetic breast and ovarian cancers.
Drew Y; Calvert H
Ann N Y Acad Sci; 2008 Sep; 1138():136-45. PubMed ID: 18837894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
